Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA.
Biol Blood Marrow Transplant. 2013 Jan;19(1):94-101. doi: 10.1016/j.bbmt.2012.08.012. Epub 2012 Aug 23.
Advances made in the field of hematopoietic stem cell transplantations (HSCT) over the past 20 years may have had an impact on the distribution of posttransplantation infections. We sought to retrospectively analyze the epidemiology and risk factors for bacterial, fungal, and viral infections in children after allogeneic HSCT in a cohort of 759 children who underwent allogeneic HSCT in a single institution between 1990 and 2009. The association between infections and risk factors of interest at 0 to 30 days, 31 to 100 days, and 101 days to 2 years posttransplantation was evaluated using logistic regression. Difference among the subtypes within each category was studied. There were 243 matched-related donors, 239 matched-unrelated donors (MUDs), and 176 haploidentical donor transplantations. Era of transplantation (0-30 days), peripheral blood stem cell product, acute graft-versus-host disease (aGVHD; 31-100 days), and chronic GVHD (cGVHD; 101-730 days) were associated with higher risk for bacterial infections at the respective time periods. Patients with aGVHD (31-100 days), cGVHD, and older age (101-730 days) were at higher risk for fungal infections. Cytomegalovirus (CMV) donor/recipient (D/R) serostatus (0-100 days), era of transplantation, MUD HSCT (31-100 days), and cGVHD (101-730 days), influenced viral infections. Gram-positive outnumbered gram-negative bacterial infections; aspergillosis and candidemia were equally prevalent in all time periods. Haploidentical donor HSCT was not associated with an increased risk of infections. There seems to be a continuum in the timeline of infections posttransplantation, with bacterial, fungal, and viral infections prevalent in all time periods, particularly late after the transplantation, the risk affected by GVHD, CMV, D/R status, product type, older age, and use of unrelated donors.
在过去的 20 年中,造血干细胞移植领域的进展可能影响了移植后感染的分布。我们试图回顾性分析 1990 年至 2009 年期间在单一机构接受同种异体造血干细胞移植的 759 名儿童的细菌、真菌和病毒感染的流行病学和危险因素。使用逻辑回归评估移植后 0-30 天、31-100 天和 101-2 年期间感染与感兴趣的危险因素之间的关联。研究了每个类别中亚型之间的差异。有 243 例匹配相关供体、239 例匹配无关供体(MUD)和 176 例单倍体相合供体移植。移植期(0-30 天)、外周血干细胞产品、急性移植物抗宿主病(aGVHD;31-100 天)和慢性移植物抗宿主病(cGVHD;101-730 天)与相应时间段细菌感染的高风险相关。患有 aGVHD(31-100 天)、cGVHD 和年龄较大(101-730 天)的患者真菌感染风险较高。巨细胞病毒(CMV)供体/受者(D/R)血清状态(0-100 天)、移植期、MUDHSCT(31-100 天)和 cGVHD(101-730 天)影响病毒感染。革兰氏阳性菌感染多于革兰氏阴性菌感染;在所有时间段,曲霉菌病和念珠菌血症的发病率相等。单倍体相合供体 HSCT 与感染风险增加无关。移植后感染的时间线似乎是连续的,细菌、真菌和病毒感染在所有时间段都很常见,尤其是移植后晚期,GVHD、CMV、D/R 状态、产品类型、年龄较大和使用无关供体的风险都会受到影响。